These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Excretion of 17-hydroxycorticosteroids under the effect of combined preparations containing separate progestagens: ethynodiol diacetate and chlormadinone]. Kloś J; Radwańska E Endokrynol Pol; 1971; 22(1):61-8. PubMed ID: 4100342 [TBL] [Abstract][Full Text] [Related]
8. The effect of various contraceptive hormonal therapies in women with normal and diabetic oral glucose tolerance test. Aznar R; Lara R; Zarco D; González L Contraception; 1976 Mar; 13(3):299-311. PubMed ID: 55331 [TBL] [Abstract][Full Text] [Related]
9. Pill-a-month as an oral contraceptive. Hefnawi F; Hassanein M; Younis N Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):1-17. PubMed ID: 12256024 [TBL] [Abstract][Full Text] [Related]
10. [Studies on the contraceptive effect of chlormadinone]. Marcinkowski Z Ginekol Pol; 1980 May; 51(5):453-65. PubMed ID: 6157607 [TBL] [Abstract][Full Text] [Related]
11. Antithrombin 3 concentration in women using low-dosage progestogen for contraception. Bergsjö P; Fagerhol MK; Abildgaard U Am J Obstet Gynecol; 1972 Apr; 112(7):938-40. PubMed ID: 4114468 [TBL] [Abstract][Full Text] [Related]
12. Lynestrenol 1 mg.-mestranol 0.1 mg: a new low dose oral contraceptive: a clinical study. Kamal I; Hefnawi F; Younis N Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):11-5. PubMed ID: 12254506 [TBL] [Abstract][Full Text] [Related]
13. Reduction of the oral contraceptive estrogen burden by alternate day estrogen administration. Segre EJ; Henzl MR; Giner J; Scheel C; Bessler S Contraception; 1975 Aug; 12(2):155-74. PubMed ID: 1139955 [TBL] [Abstract][Full Text] [Related]
14. Invluence of oral contraceptives on circulating immune response. II. Effect of progestogenic and estrogenic components. Rangnekar KN; Rao SS; Joshi UM Contraception; 1974 Nov; 10(5):527-33. PubMed ID: 4141295 [TBL] [Abstract][Full Text] [Related]
15. Clinical studies with a low dose estrogen-progestogen combination. Sartoretto JN; Ortega-Recio JC; Moraes R; Filho FN Contraception; 1977 May; 15(5):563-70. PubMed ID: 880827 [TBL] [Abstract][Full Text] [Related]
17. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol. Akerlund M; Røde A; Westergaard J Br J Obstet Gynaecol; 1993 Sep; 100(9):832-8. PubMed ID: 8218004 [TBL] [Abstract][Full Text] [Related]
18. Experience with ethynodiol diacetate and mestranol as an oral contraceptive. Gidwani GP; Purandare BN J Obstet Gynaecol India; 1968 Apr; 18(2):287-93. PubMed ID: 12331821 [TBL] [Abstract][Full Text] [Related]
19. Problems in evaluating chronic toxicity of contraceptive steroids in dogs. Weikel JH; Nelson LW J Toxicol Environ Health; 1977 Sep; 3(1-2):167-77. PubMed ID: 72828 [TBL] [Abstract][Full Text] [Related]
20. Use of Anovlar in gynaecological disorders and contraception. Shahani SM; Chiklikar A J Obstet Gynaecol India; 1968 Apr; 18(2):592-7. PubMed ID: 12331827 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]